David A. Lipson, M.D.

Assistant Professor of Medicine
Director, Obstructive Lung Disease Program Director, Adult Cystic Fibrosis Program
Associate Director, Education and Fellowship
Training

University of Pennsylvania Medical Center
Pulmonary, Allergy & Critical Care Division
821 West Gates Building
3400 Spruce Street
Philadelphia, PA 19104-4283
tel.: (215) 349-5478
fax: (215) 614-0869
email: dlipson@mail.med.upenn.edu

Education:

MD: Thomas Jefferson University

Residency: Hospital of the University of Pennsylvania

Fellowship: Hospital of the University of Pennsylvania

Dr. Lipson is an Assistant Professor of Medicine in the Pulmonary, Allergy, and Critical Care Division and serves as the Director of the Obstructive Lung Disease Program and the Adult Cystic Fibrosis Program at Penn. His clinical interests include Chronic Obstructive Pulmonary Disease, adult cystic fibrosis, and bronchiectasis. He serves as an attending physician on the Advanced Lung Disease and Lung Transplantation Service, as well as in the Medical Intensive Care Unit at the Hospital of the University of Pennsylvania. Dr. Lipson is the Associate Director of the Pulmonary and Critical Care Fellowship Training Program at Penn.

In addition to his clinical duties, Dr. Lipson is heavily involved in clinical research. He was awarded a NIH K23 grant to determine clinical risk factors for the development of obliterative bronchiolitis (OB -- chronic lung rejection) following lung transplantation. Additionally, he is studying the use of hyperpolarized helium-3 MRI in the early detection of OB. Dr. Lipson is also interested in novel, non-invasive radiologic imaging techniques in order to study ventilation and perfusion relationships in the lung.

Dr. Lipson completed his undergraduate work at the University of Pennsylvania where he graduated cum laude and with Distinction in the Major. He then obtained his MD degree at Jefferson Medical College. At Jefferson, he was awarded the W.W. Smith Scholarship for academic achievement and was elected to the Hobart Amory Hare Medical Honor Society. Dr. Lipson subsequently returned to Penn for his internship and residency in Internal Medicine. Following his residency, Dr. Lipson completed his Pulmonary and Critical Care training at Penn where he received the 2000-2001 Will Rogers Institute Fellowship Award. The American Board of Internal Medicine (ABIM) currently boards him in Medicine, Pulmonary Disease, and Critical Care. He currently serves as physician-secretary of the Pulmonary Disease Board of the ABIM.

Representative Publications:

Lipson DA, van Beek EJR. Eds. Functional Lung Imaging. Taylor Francis, Inc. Publisher. New York, New York. (2005).

Lipson DA. Redefining Treatment in COPD: New Directions in Bronchodilator Therapy. Treatments in Respiratory Medicine. 3(2):89-95. (2004).

Lipson DA, Roberts DA, Hansen-Flaschen J, Gentile TR, Jones G, Thompson A, Dimitrov IE, Palevsky HI, Leigh JS, Schnall M, and Rizi RR. Pulmonary Ventilation and Perfusion Scanning Using Hyperpolarized Helium-3 MRI and Arterial Spin Tagging in Healthy Normal Subjects, and in Pulmonary Embolism, and Orthotopic Lung Transplant Patients. Magnetic Resonance in Medicine, 47:1073-1076 (2002).

Lipson DA, Edelman JD, Palevsky HI. Alternatives to Lung Transplantation: Lung Volume Reduction Surgery and Continuous Intravenous Prostacyclin. Transplant Proc, 34(4):1283-1286. (2002).

Kotloff RM, Hansen-Flaschen J, Lipson DA, Tino G, Arcasoy SM, Kaiser LR, and Alavi A. Apical Perfusion Fraction as a Predictor of Short Term Functional Outcome Following Bilateral Lung Volume Reduction Surgery. Chest, 120(5):1609-1615 (2001).

Lipson DA, Palevsky HI, Kotloff RM, and Edelman J. Conversion to Tacrolimus (FK 506) from Cyclosporine After Orthotopic Lung Transplantation.Transplant Proc, 30(4):1505-1507 (1998).